Latest Headlines

  1. London Biotechnology Show 2026 To Unite Global Life Sciences Leaders, Innovators, Investors 10/29/2026

    The London Biotechnology Show 2026 will return to ExCeL London on 18–19 November, bringing together biotechnology and pharmaceutical companies, researchers, healthcare professionals, investors, policymakers and technology providers to explore the breakthroughs and commercial opportunities shaping the future of life sciences.

  2. Revvity Launches Signals LabGistics Solution To Connect And Orchestrate Scientific Workflows 10/21/2026

    Revvity, Inc. (NYSE: RVTY), announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.

  3. Pharmaceutical Online Covers Honorable Mention FOYA Award Winner, Chugai Pharmaceutical Co., Ltd. 10/13/2026

    Chugai Pharmaceutical Co., Ltd. is advancing pharmaceutical manufacturing through extensive automation at its FJ3 active pharmaceutical ingredient (API) production facility, a project that was recently recognized with a 2026 ISPE Facility of the Year Awards (FOYA) Honorable Mention.

  4. Emerson Expands Life Sciences Scheduling Software To Optimize Quality Control Lab Testing 10/13/2026

    Global automation leader Emerson today announced an enhancement to its DeltaV™ Real-Time Scheduling (RTS) software that extends integrated, real-time manufacturing scheduling capabilities to quality control (QC) labs.

  5. Contec Launches Sterile ReadySAT™ With PeridoxRTU® Sporicidal Wipes For Cleanrooms 10/7/2026

    Contec, Inc. announces the launch of sterile ReadySAT™ with PeridoxRTU® Sporicidal Wipes. Validated sterile and suitable for ISO 3-8 cleanrooms, the wipes support surface disinfection in the most critical cleanroom environments.

  6. Germfree Launches Biopharmaceutical Isolator For Advanced Therapy Workflows 10/5/2026

    Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences, healthcare and biocontainment, today launched a new aseptic biopharmaceutical isolator designed to provide a flexible, modular Grade A processing environment for cell and gene therapy (CGT) applications. The new technology, made and serviced in the U.S., will enable CGT developers to bolster their contamination control strategy around open steps in manufacturing workflows. 

  7. Improving Vaccine Research Workflows Using Dependable Liquid Handling 10/2/2026

    The Wagner group at the University of Regensburg’s Institute of Medical Microbiology and Hygiene relies on liquid handling solutions from INTEGRA Biosciences to aid its vital research into molecular virology and vaccine development.

  8. Streamlining Genotyping With The INTEGRA VOYAGER Pipette 10/2/2026

    The Robling Lab at Indiana University School of Medicine uses liquid handling solutions from INTEGRA Biosciences to aid its vital research into bone development and homeostasis.

  9. Streamlining Cell Cultures With INTEGRA's VACUSAFE To Advance Respiratory Health Research 10/2/2026

    Researchers at the University of Technology Sydney (UTS), Australia, rely on the VACUBOY vacuum hand operator and VACUSAFE aspiration system from INTEGRA Biosciences to aid their research into respiratory health.

  10. INTEGRA Clean-Up Week: Employees Send A Clear Signal For Sustainability And Responsibility 10/2/2026

    INTEGRA Biosciences carried out a cross-site Clean-Up Week in September 2026 at its main sites in Zizers, Switzerland, and Hudson/Merrimack, US. Over the course of a week, employees contributed to a more organized work environment, a more conscious use of resources, and a cleaner environment, both within the company and in the areas surrounding the sites.